These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26254217)

  • 21. Modulation of Lymphangiogenesis in Incisional Murine Diabetic Wound Healing Using Negative Pressure Wound Therapy.
    Wu M; Matar DY; Yu Z; Chen Z; Knoedler S; Ng B; Darwish O; Haug V; Friedman L; Orgill DP; Panayi AC
    Adv Wound Care (New Rochelle); 2023 Sep; 12(9):483-497. PubMed ID: 36424821
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
    Cao Y; Zhong W
    Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between lymphangiogenesis and exudates during the wound-healing process of mouse skin full-thickness wound.
    Shimamura K; Nakatani T; Ueda A; Sugama J; Okuwa M
    Wound Repair Regen; 2009; 17(4):598-605. PubMed ID: 19614925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphangiogenesis in the bone-implant interface of orthopedic implants: importance and consequence.
    Jell G; Kerjaschki D; Revell P; Al-Saffar N
    J Biomed Mater Res A; 2006 Apr; 77(1):119-27. PubMed ID: 16392126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Merkel cell carcinoma induces lymphatic microvessel formation.
    Werchau S; Toberer F; Enk A; Dammann R; Helmbold P
    J Am Acad Dermatol; 2012 Aug; 67(2):215-25. PubMed ID: 22050913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressed recruitment of alternatively activated macrophages reduces TGF-β1 and impairs wound healing in streptozotocin-induced diabetic mice.
    Okizaki S; Ito Y; Hosono K; Oba K; Ohkubo H; Amano H; Shichiri M; Majima M
    Biomed Pharmacother; 2015 Mar; 70():317-25. PubMed ID: 25677561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis.
    Schledzewski K; Falkowski M; Moldenhauer G; Metharom P; Kzhyshkowska J; Ganss R; Demory A; Falkowska-Hansen B; Kurzen H; Ugurel S; Geginat G; Arnold B; Goerdt S
    J Pathol; 2006 May; 209(1):67-77. PubMed ID: 16482496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
    Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
    Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular lymphangiogenesis: new players.
    Tammela T; Petrova TV; Alitalo K
    Trends Cell Biol; 2005 Aug; 15(8):434-41. PubMed ID: 16005628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin.
    Goldman J; Le TX; Skobe M; Swartz MA
    Circ Res; 2005 Jun; 96(11):1193-9. PubMed ID: 15890974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A; Detmar M
    Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucocele: a human model for lymphangiogenesis.
    Castro EC; Galambos C
    Pediatr Dev Pathol; 2009; 12(3):222-8. PubMed ID: 18937525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
    Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
    Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy.
    Stacker SA; Achen MG
    Lymphat Res Biol; 2008; 6(3-4):165-72. PubMed ID: 19093789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphatic vessels assessment in feline mammary tumours.
    Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
    BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A system for quantifying the patterning of the lymphatic vasculature.
    Shayan R; Karnezis T; Tsantikos E; Williams SP; Runting AS; Ashton MW; Achen MG; Hibbs ML; Stacker SA
    Growth Factors; 2007 Dec; 25(6):417-25. PubMed ID: 18365872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Ear Sponge Lymphangiogenesis Assay.
    Akwii RG; Sajib MS; Zahra FT; Madala HR; Srivenugopal KS; Mikelis CM
    Methods Mol Biol; 2021; 2193():85-96. PubMed ID: 32808261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.